Cargando…

No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area

BACKGROUND: Schistosomiasis is a debilitating neglected tropical disease that infects over 200 million people worldwide. To combat this disease, in 2012, the World Health Organization announced a goal of reducing and eliminating transmission of schistosomes. Current control focuses primarily on mass...

Descripción completa

Detalles Bibliográficos
Autores principales: Lelo, Agola E., Mburu, David N., Magoma, Gabriel N., Mungai, Ben N., Kihara, Jimmy H., Mwangi, Ibrahim N., Maina, Geoffrey M., Kinuthia, Joseph M., Mutuku, Martin W., Loker, Eric S., Mkoji, Gerald M., Steinauer, Michelle L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191953/
https://www.ncbi.nlm.nih.gov/pubmed/25299057
http://dx.doi.org/10.1371/journal.pntd.0003221
_version_ 1782338727635320832
author Lelo, Agola E.
Mburu, David N.
Magoma, Gabriel N.
Mungai, Ben N.
Kihara, Jimmy H.
Mwangi, Ibrahim N.
Maina, Geoffrey M.
Kinuthia, Joseph M.
Mutuku, Martin W.
Loker, Eric S.
Mkoji, Gerald M.
Steinauer, Michelle L.
author_facet Lelo, Agola E.
Mburu, David N.
Magoma, Gabriel N.
Mungai, Ben N.
Kihara, Jimmy H.
Mwangi, Ibrahim N.
Maina, Geoffrey M.
Kinuthia, Joseph M.
Mutuku, Martin W.
Loker, Eric S.
Mkoji, Gerald M.
Steinauer, Michelle L.
author_sort Lelo, Agola E.
collection PubMed
description BACKGROUND: Schistosomiasis is a debilitating neglected tropical disease that infects over 200 million people worldwide. To combat this disease, in 2012, the World Health Organization announced a goal of reducing and eliminating transmission of schistosomes. Current control focuses primarily on mass drug administration (MDA). Therefore, we monitored transmission of Schistosoma mansoni via fecal egg counts and genetic markers in a typical school based MDA setting to ascertain the actual impacts of MDA on the targeted schistosome population. METHODS: For 4 years, we followed 67 children enrolled in a MDA program in Kenya. Infection status and egg counts were measured each year prior to treatment. For 15 of these children, for which there was no evidence of acquired resistance, meaning they became re-infected following each treatment, we collected microsatellite genotype data from schistosomes passed in fecal samples as a representation of the force of transmission between drug treatments. We genotyped a total of 4938 parasites from these children, with an average of 329.2 parasites per child for the entire study, and an average of 82.3 parasites per child per annual examination. We compared prevalence, egg counts, and genetic measures including allelic richness, gene diversity (expected heterozygosity), adult worm burdens and effective number of breeders among time points to search for evidence for a change in transmission or schistosome populations during the MDA program. FINDINGS: We found no evidence of reduced transmission or schistosome population decline over the course of the program. Although prevalence declined in the 67 children as it did in the overall program, reinfection rates were high, and for the 15 children studied in detail, schistosome egg counts and estimated adult worm burdens did not decline between years 1 and 4, and genetic diversity increased over the course of drug treatment. INTERPRETATION: School based control programs undoubtedly improve the health of individuals; however, our data show that in an endemic area, such a program has had no obvious effect on reducing transmission or of significantly impacting the schistosome population as sampled by the children we studied in depth. Results like these, in combination with other sources of information, suggest more integrated approaches for interrupting transmission and significantly diminishing schistosome populations will be required to achieve sustainable control.
format Online
Article
Text
id pubmed-4191953
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41919532014-10-14 No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area Lelo, Agola E. Mburu, David N. Magoma, Gabriel N. Mungai, Ben N. Kihara, Jimmy H. Mwangi, Ibrahim N. Maina, Geoffrey M. Kinuthia, Joseph M. Mutuku, Martin W. Loker, Eric S. Mkoji, Gerald M. Steinauer, Michelle L. PLoS Negl Trop Dis Research Article BACKGROUND: Schistosomiasis is a debilitating neglected tropical disease that infects over 200 million people worldwide. To combat this disease, in 2012, the World Health Organization announced a goal of reducing and eliminating transmission of schistosomes. Current control focuses primarily on mass drug administration (MDA). Therefore, we monitored transmission of Schistosoma mansoni via fecal egg counts and genetic markers in a typical school based MDA setting to ascertain the actual impacts of MDA on the targeted schistosome population. METHODS: For 4 years, we followed 67 children enrolled in a MDA program in Kenya. Infection status and egg counts were measured each year prior to treatment. For 15 of these children, for which there was no evidence of acquired resistance, meaning they became re-infected following each treatment, we collected microsatellite genotype data from schistosomes passed in fecal samples as a representation of the force of transmission between drug treatments. We genotyped a total of 4938 parasites from these children, with an average of 329.2 parasites per child for the entire study, and an average of 82.3 parasites per child per annual examination. We compared prevalence, egg counts, and genetic measures including allelic richness, gene diversity (expected heterozygosity), adult worm burdens and effective number of breeders among time points to search for evidence for a change in transmission or schistosome populations during the MDA program. FINDINGS: We found no evidence of reduced transmission or schistosome population decline over the course of the program. Although prevalence declined in the 67 children as it did in the overall program, reinfection rates were high, and for the 15 children studied in detail, schistosome egg counts and estimated adult worm burdens did not decline between years 1 and 4, and genetic diversity increased over the course of drug treatment. INTERPRETATION: School based control programs undoubtedly improve the health of individuals; however, our data show that in an endemic area, such a program has had no obvious effect on reducing transmission or of significantly impacting the schistosome population as sampled by the children we studied in depth. Results like these, in combination with other sources of information, suggest more integrated approaches for interrupting transmission and significantly diminishing schistosome populations will be required to achieve sustainable control. Public Library of Science 2014-10-09 /pmc/articles/PMC4191953/ /pubmed/25299057 http://dx.doi.org/10.1371/journal.pntd.0003221 Text en © 2014 Lelo et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Lelo, Agola E.
Mburu, David N.
Magoma, Gabriel N.
Mungai, Ben N.
Kihara, Jimmy H.
Mwangi, Ibrahim N.
Maina, Geoffrey M.
Kinuthia, Joseph M.
Mutuku, Martin W.
Loker, Eric S.
Mkoji, Gerald M.
Steinauer, Michelle L.
No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
title No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
title_full No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
title_fullStr No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
title_full_unstemmed No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
title_short No Apparent Reduction in Schistosome Burden or Genetic Diversity Following Four Years of School-Based Mass Drug Administration in Mwea, Central Kenya, a Heavy Transmission Area
title_sort no apparent reduction in schistosome burden or genetic diversity following four years of school-based mass drug administration in mwea, central kenya, a heavy transmission area
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191953/
https://www.ncbi.nlm.nih.gov/pubmed/25299057
http://dx.doi.org/10.1371/journal.pntd.0003221
work_keys_str_mv AT leloagolae noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT mburudavidn noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT magomagabrieln noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT mungaibenn noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT kiharajimmyh noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT mwangiibrahimn noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT mainageoffreym noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT kinuthiajosephm noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT mutukumartinw noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT lokererics noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT mkojigeraldm noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea
AT steinauermichellel noapparentreductioninschistosomeburdenorgeneticdiversityfollowingfouryearsofschoolbasedmassdrugadministrationinmweacentralkenyaaheavytransmissionarea